Claritas Pharmaceuticals, Inc.
Claritas Pharmaceuticals, Inc. (CLAZF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CLAZF · as of Jun 8, 2026
Key Statistics
Explore Claritas Pharmaceuticals, Inc. Data
clazf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
clazf competitorsCLAZF
AIHLF
CCHWF
CKDXF
IMUN
IVEVFStock Performance
Full HistoryAbout Claritas Pharmaceuticals, Inc.
Claritas Pharmaceuticals, Inc. a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly k…
what is claritas pharmaceuticals, inc. · clazf stock overview · claritas pharmaceuticals, inc. company profile · who is claritas pharmaceuticals, inc. ceo · clazf OTC · claritas pharmaceuticals, inc. headquarters · claritas pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Claritas Pharmaceuticals, Inc. (CLAZF) is a Healthcare company in the Biotechnology industry, listed on OTC since Apr 12, 2016. As of the latest trading session, CLAZF stock price is $0.00, with a market capitalization of $3,659. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2020, Claritas Pharmaceuticals, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Claritas Pharmaceuticals, Inc. (CLAZF) stock price is $0.00. The stock is traded on OTC under the ticker symbol CLAZF. The 52-week range is $0.00 – $0.00.